[ad_1]
French President Emmanuel Macron / Photo = AP
French President Emmanuel Macron has raised doubts about the effectiveness of the new coronavirus vaccine (Corona 19) from British pharmaceutical company AstraZeneca.
According to the AFP news agency, President Macron met with journalists on the 29th (local time) and said: “I think it is not valid for people over 65 years old. We do not recommend AstraZeneca to people between 60 and 65 years old.” results obtained.”
The comments came a few hours before the European Medicines Agency recommended conditional marketing approval for the AstraZeneca vaccine. France is reported to announce the approval of its own health authorities early next week.
In order to spread the vaccine quickly, the UK’s vaccination policy, which has decided to extend the interval between the first and second doses to a maximum of 12 weeks, remained frank.
In response, President Macron said: “Scientists explain that the mutant virus spreads because the virus adapts to less immunity with one dose.” In addition, he insisted that it was a “lie” to say that he only gave the first vaccination and was vaccinated.
In response, the British Daily Telegraph reported that British political and scientific circles were criticizing President Macron’s comments as “uncommon sense”.
Meanwhile, the British Daily Guardian and the BBC broadcast on the 26th (hereafter local time), “European Medicines Agency (EMA) Commissioner Emma Cook attended the European Parliament Health Committee and approved” (AstraZeneca vaccine ) to be used only by certain age groups. “There is a possibility to do so and it can be made available to a wide range of age groups.”
“Because there is not enough data on how this vaccine works for people over 65,” Cook said. “So far, only a few studies have been done to see if it works for the elderly. Only a small number of studies have been done with a focus on specific age groups. There is a possibility that a concluding conclusion will be reached. “.
Previously, criticism has been raised for the lack of clinical studies on the AstraZeneca vaccine in people over 55 years of age.
Kim Jeong-ho, Guest Reporter for Hankyung.com [email protected]
Ⓒ Hankyung.com prohibits unauthorized reproduction and redistribution
